Colonial Trust Advisors lowered its stake in Walgreens Boots Alliance (NASDAQ:WBA) by 20.8% during the first quarter, according to its most recent Form 13F filing with the SEC. The firm owned 18,782 shares of the pharmacy operator’s stock after selling 4,927 shares during the period. Colonial Trust Advisors’ holdings in Walgreens Boots Alliance were worth $1,230,000 as of its most recent filing with the SEC.
Several other hedge funds and other institutional investors also recently modified their holdings of the stock. Parkside Investments LLC grew its position in Walgreens Boots Alliance by 3.0% in the fourth quarter. Parkside Investments LLC now owns 24,806 shares of the pharmacy operator’s stock valued at $1,801,000 after acquiring an additional 715 shares during the last quarter. BTIM Corp. grew its position in Walgreens Boots Alliance by 3.5% in the fourth quarter. BTIM Corp. now owns 21,457 shares of the pharmacy operator’s stock valued at $1,558,000 after acquiring an additional 725 shares during the last quarter. Eads & Heald Investment Counsel grew its position in Walgreens Boots Alliance by 3.6% in the fourth quarter. Eads & Heald Investment Counsel now owns 21,249 shares of the pharmacy operator’s stock valued at $1,543,000 after acquiring an additional 748 shares during the last quarter. Carnegie Capital Asset Management LLC grew its position in Walgreens Boots Alliance by 3.3% in the fourth quarter. Carnegie Capital Asset Management LLC now owns 24,680 shares of the pharmacy operator’s stock valued at $1,783,000 after acquiring an additional 790 shares during the last quarter. Finally, Alpha Omega Wealth Management LLC grew its position in Walgreens Boots Alliance by 100.0% in the first quarter. Alpha Omega Wealth Management LLC now owns 1,600 shares of the pharmacy operator’s stock valued at $105,000 after acquiring an additional 800 shares during the last quarter. Institutional investors own 60.57% of the company’s stock.
WBA has been the topic of a number of recent analyst reports. Mizuho set a $87.00 target price on Walgreens Boots Alliance and gave the company a “buy” rating in a research report on Wednesday, January 24th. Royal Bank of Canada set a $94.00 target price on Walgreens Boots Alliance and gave the company a “buy” rating in a research report on Friday, February 16th. Zacks Investment Research raised Walgreens Boots Alliance from a “hold” rating to a “buy” rating and set a $76.00 price target on the stock in a research note on Wednesday, February 14th. Loop Capital set a $90.00 price target on Walgreens Boots Alliance and gave the company a “buy” rating in a research note on Tuesday, February 13th. Finally, Jefferies Group set a $85.00 price target on Walgreens Boots Alliance and gave the company a “buy” rating in a research note on Tuesday, April 3rd. Two investment analysts have rated the stock with a sell rating, nine have assigned a hold rating, thirteen have assigned a buy rating and one has assigned a strong buy rating to the stock. The stock presently has an average rating of “Buy” and a consensus price target of $83.20.
Walgreens Boots Alliance stock opened at $64.23 on Wednesday. The company has a current ratio of 0.90, a quick ratio of 0.45 and a debt-to-equity ratio of 0.44. The company has a market capitalization of $63.80 billion, a P/E ratio of 12.59, a P/E/G ratio of 1.04 and a beta of 1.15. Walgreens Boots Alliance has a one year low of $61.56 and a one year high of $83.89.
Walgreens Boots Alliance (NASDAQ:WBA) last posted its quarterly earnings data on Wednesday, March 28th. The pharmacy operator reported $1.73 EPS for the quarter, topping the Zacks’ consensus estimate of $1.55 by $0.18. The company had revenue of $33.02 billion for the quarter, compared to analyst estimates of $32.20 billion. Walgreens Boots Alliance had a return on equity of 20.38% and a net margin of 3.33%. The firm’s quarterly revenue was up 12.1% on a year-over-year basis. During the same period in the previous year, the firm earned $1.36 earnings per share. equities analysts predict that Walgreens Boots Alliance will post 5.92 earnings per share for the current fiscal year.
The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 12th. Investors of record on Friday, May 18th will be paid a $0.40 dividend. This represents a $1.60 dividend on an annualized basis and a dividend yield of 2.49%. The ex-dividend date of this dividend is Thursday, May 17th. Walgreens Boots Alliance’s dividend payout ratio is currently 31.37%.
In related news, Director William C. Foote sold 2,736 shares of Walgreens Boots Alliance stock in a transaction that occurred on Wednesday, May 2nd. The stock was sold at an average price of $65.56, for a total value of $179,372.16. Following the transaction, the director now directly owns 13,679 shares of the company’s stock, valued at $896,795.24. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. 14.80% of the stock is owned by insiders.
Walgreens Boots Alliance Company Profile
Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of general merchandise, including non-prescription drugs, beauty products, photo finishing, seasonal merchandise, greeting cards, and convenience foods through its retail drugstores and convenient care clinics.
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.